bpc-157 fsa eligible For Knee Pain: Early Reported Outcomes, A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, BPC-157 Vial - Frontier Peptide
Description
Aaron Kesselheim, a pharmacoepidemiology and pharmacoeconomics expert who somehow always makes time for my random email requests and has a gift for explaining drugs and the complicated regulatory terrain

Always double-check values against your vials COA and labelling

Patients may experience some mild discomfort after the procedure, but this usually goes away within a few days

A temporary drop in potassium This is the most clinically recognised reason to feel worse early in treatment

It is uncommon to not get enough vitamin B12 from your diet but can be an issue especially if you do not eat animal products and follow a vegan or strict vegetarian diet without eating B12 fortified foods or taking a supplement

So A + for immunity, A for wound healing
